Isabela Biscaia

Dr. Isabela Biscaia

Universidade Estadual do Centro-Oeste
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Isabela BiscaiaIsabela Biscaia
Isabela Biscaia
SGSamantha Nascimento Gomes
Samantha Nascimento Gomes
LBLarissa Bernardi
Larissa Bernardi
Paulo Renato De OliveiraPaulo Renato De Oliveira
Paulo Renato De Oliveira
Cocrystals have gained attention in the pharmaceutical industry due to their ability to improve solubility, stability, in vitro dissolution rate, and bioavailability of poorly soluble drugs. Conceptually, cocrystals are multicomponent solids that contain two or more neutral molecules in stoichiometric amounts within the same crystal lattice. There are several techniques for obtaining cocrystals described in the literature; however, the focus of this article is the Reaction Crystallization Method (RCM). This method is based on the generation of a supersaturated solution with respect to the cocrystal, while this same solution is saturated or unsaturated with respect to the components of the cocrystal individually. The advantages of the RCM compared with other cocrystallization techniques include the ability to form cocrystals without crystallization of individual components, applicability to the development of in situ techniques for the screening of high quality cocrystals, possibility of large-scale production, and lower cost in both time and materials. An increasing number of scientific studies have demonstrated the use of RCM to synthesize cocrystals, mainly for drugs belonging to class II of the Biopharmaceutics Classification System. The promising results obtained by RCM have demonstrated the applicability of the method for obtaining pharmaceutical cocrystals that improve the biopharmaceutical characteristics of drugs.

27 September 2019 in Materials
Verified
Journal Article
Open access
PDF file
RMRafaela Z. C. Meira
Rafaela Z. C. Meira
Isabela BiscaiaIsabela Biscaia
Isabela Biscaia
CNCamila Nogueira
Camila Nogueira
Fábio Seigi MurakamiFábio Seigi Murakami
Fábio Seigi Murakami
LBLarissa Bernardi
Larissa Bernardi
Paulo Renato De OliveiraPaulo Renato De Oliveira
Paulo Renato De Oliveira
The physical and chemical characterization of the solid-state properties of drugs and excipients is fundamental for planning new formulations and developing new strategies for the treatment of diseases. Techniques such as differential scanning calorimetry, thermogravimetry, X-ray powder diffraction, Fourier transform infrared spectroscopy, and scanning electron microscopy are among the most commonly used techniques for these purposes. Penciclovir and lysine are individually used to treat the herpes virus. As such, the development of a formulation containing both drugs may have therapeutic potential. Solid-state characterization showed that both penciclovir and lysine were crystalline materials with melting points at 278.27 °C and 260.91 °C, respectively. Compatibility studies of penciclovir and lysine indicated a possible interaction between these substances, as evidenced by a single melting point at 253.10 °C. The compatibility of several excipients, including ethylenediaminetetraacetic acid, cetostearyl alcohol, sodium lauryl sulphate, di-tert-butyl methyl phenol, liquid petrolatum, methylparaben, nonionic wax, paraffin, propylene glycol, and propylparaben, was evaluated in ternary (penciclovir-lysine-excipient) mixtures (1:1:1, w/w/w) to determine the optimal formulation. The developed formulation was stable under accelerated and ambient conditions, which demonstrated that the interaction between penciclovir and lysine was suitable for the development of a formulation containing both drugs.

26 August 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SGSamantha Nascimento Gomes
Samantha Nascimento Gomes
Isabela BiscaiaIsabela Biscaia
Isabela Biscaia
DLDiana Schon Lopes
Diana Schon Lopes
MMMariana Mengarda
Mariana Mengarda
Fábio Seigi MurakamiFábio Seigi Murakami
Fábio Seigi Murakami
LBLarissa Bernardi
Larissa Bernardi
A solvate cocrystal of the antimicrobial norfloxacin (NFX) was formed by using isonicotinamide (INA) as a coformer with the solvent evaporation technique. The cocrystal formation was confirmed by performing solid-state characterization techniques. We evaluated the dissolution under supersaturated conditions and also the solubility at the vertex of triphasic domain of cocrystal and NFX in both water and Fasted-State Simulated Intestinal Fluid (FaSSIF). The antimicrobial activity was evaluated using the microdilution technique. The cocrystal showed 1.8 times higher dissolution than NFX in water at 60 min and 1.3 times higher in FaSSIF at 180 min in the kinetic study. The cocrystal also had an increase in solubility of 8.38 times in water and 6.41 times in FaSSIF. The biopharmaceutical properties of NFX with cocrystallization improved antimicrobial action, as shown in the results of minimum inhibitory concentration (MIC) and inhibitory concentrations of 50% (IC50%) and 90% (IC90%). This paper presents, for the first time, a more in-depth analysis of the cocrystal of NFX–INA concerning its dissolution, solubility, and antimicrobial activity. In all these criteria, the cocrystal obtained better results compared to the pure drug.

1 January 2020 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
Isabela BiscaiaIsabela Biscaia
Isabela Biscaia
VTVitor Todeschini
Vitor Todeschini
RMRafaela de Meira
Rafaela de Meira
CNCamila Nogueira
Camila Nogueira
LBLarissa Bernardi
Larissa Bernardi
Paulo Renato De OliveiraPaulo Renato De Oliveira
Paulo Renato De Oliveira

23 January 2020 in Current Pharmaceutical Analysis
Verified
Journal Article
Closed access
PDF file
LBLarissa Sakis Bernardi
Larissa Sakis Bernardi
PJPedro Nicolau Severino Júnior
Pedro Nicolau Severino Júnior
Isabela BiscaiaIsabela Biscaia
Isabela Biscaia
MSMaximiliano da Silva Sangoi
Maximiliano da Silva Sangoi
VTVitor Todeschini
Vitor Todeschini
Paulo Renato De OliveiraPaulo Renato De Oliveira
Paulo Renato De Oliveira
Background: Hydrochlorothiazide (HCTZ) is a thiazide diuretic which comprises two sulfonamide groups. The literature is not clear regarding the identification of the chromatographic peaks of its two major related substances: chlorothiazide and 4-amino-6-chloro-1,3-benzenedisulfonamide (DSA). Methods: In the present study, a simple, sensitive, and selective HPLC method was developed and validated for the assay of HCTZ, Chlorothiazide and DSA. The method was carried out on a C18 column, maintained at 40ºC. The mobile phase was composed of monobasic potassium phosphate buffer 0.02M pH 3.0/acetonitrile/methanol (82:9:9, v/v/v), run at a flow rate of 1.0 mL/min, and UV detection at 270 nm. Results: All related compounds including processing impurities and degradants from stressed samples were well separated from each other. The performance of this method was validated in accordance to the ICH guidelines and included specificity, linearity, limit of detection, limit of quantification, accuracy, precision and robustness. Conclusion: Based on the results, the HCTZ degradation pathway was proposed and the validated HPLC method was successfully applied to the quantitative analysis of HCTZ in pharmaceutical formulations, contributing to improve quality control, to assure therapeutic efficacy and to clarify the literature.

1 January 2025
Verified
Book Chapter
Open access
PDF file
Isabela BiscaiaIsabela Biscaia
Isabela Biscaia
SGSamantha Nascimento Gomes
Samantha Nascimento Gomes
PBPatrícia Bubna Biscaia
Patrícia Bubna Biscaia
ECEllen Schavarski Chade
Ellen Schavarski Chade
MAMaria Clara de Aquino
Maria Clara de Aquino
Este artigo consiste em uma revisão bibliográfica baseada nas principais bibliotecas eletrônicas e bases de dados científicas internacionais, com o objetivo de sintetizar informações atualizadas sobre Bacteroides fragilis e oferecer subsídios para a atuação dos profissionais de saúde. B. fragilis integra a microbiota intestinal humana e desempenha papel fundamental na manutenção da homeostase, contribuindo para o equilíbrio microbiano e a modulação do sistema imunológico. No entanto, cepas enterotoxigênicas de B. fragilis (ETBF) estão associadas a distúrbios intestinais e podem atuar como fator desencadeante no desenvolvimento do câncer colorretal. Em situações de ruptura da barreira epitelial intestinal, a bactéria pode atravessar tecidos e causar infecções graves, como peritonite e bacteremia, especialmente em pacientes hospitalizados submetidos a procedimentos cirúrgicos. Uma das principais preocupações relacionadas a B. fragilis é sua expressiva resistência a antibióticos amplamente utilizados, como tetraciclinas, amoxicilina e ampicilina, o que reforça a urgência de estratégias eficazes para conter a disseminação da resistência antimicrobiana.